Stockreport

Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000

Cingulate Inc.  (CING) 
PDF KANSAS CITY, Kan., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR [Read more]